Mexico puts continuity of breast cancer care alongside early detection

Mexico's Health Ministry said early detection of breast cancer has value only when patients can move through the rest of the care pathway, including additional tests and treatment. Officials made that case at an Oct. 22 symposium titled “Listen, include and transform.” Rafael Ricardo Valdez Vázquez, undersecretary for health policy and population wellbeing, described prevention, timely detection, diagnostic confirmation, treatment and patient support as connected parts of the national health strategy.

One concrete example cited by the ministry was its network of Regional Centers for Remote Interpretation of Mammography Studies. The centers provide reading support to medical units that lack specialized radiology staff. From September 2025 through September 2026, they interpreted more than 29,600 studies, with an average response time of four days, the ministry said. That figure does not describe the country's overall screening wait or the time a patient takes to begin treatment: it measures the studies read remotely by these centers and their response time.

Valdez Vázquez said the second phase of the National Intersectoral Campaign for the Prevention, Detection and Care of Breast and Cervical Cancer began on Sept. 23, 2026. The campaign had started in October 2025 across all 32 states. The ministry said the new phase uses a human-rights, equity and intercultural approach intended to account for differing conditions of access to health services. A nationwide campaign does not mean every community has the same number of machines, specialists or appointments; the stated policy goal is to adapt services to different access conditions.

The ministry's account placed particular emphasis on what happens after screening. A mammogram finding on its own is not a confirmed diagnosis. Follow-up examinations and access to appropriate treatment are later steps in the care pathway. María Alejandra Alegría Arrieta, head of the ministry's Unit for Social Participation and Liaison, said patients' experiences and needs should inform decisions alongside scientific and medical knowledge. National Medical Care Protocols are intended to translate specialized knowledge into practical guidance for first-contact clinicians, including recognizing symptoms, explaining options and making evidence-based referrals.

Teresa Ramos Arreola, director general of the National Center for Gender Equality, Sexual and Reproductive Health, said policy must address barriers faced by women who live far from health facilities, work long hours or have caregiving duties that make it difficult to seek care for themselves. Those factors help explain the gap between a screening program's formal availability and a person's ability to use it. The ministry also said information and scientific advances should reach communities in accessible forms, including Indigenous communities, and respond to women's varied circumstances.

The symposium opened a photographic exhibition, “It's in your hands,” featuring 11 portraits of women under 40 living with breast cancer. It presents experiences after diagnosis, treatment and the challenges of daily life and health care. The ministry's announcement did not set a new national screening target, a countrywide waiting-time standard or a count of completed treatments. Its significance lies instead in describing a care model that links screening to diagnosis and treatment, and in reporting a year's workload for the remote interpretation network.